DelMar Pharma Receives Notice of Allowance on Key Patent for VAL-083 From the US Patent and Trademark Office Jul 2, 2013
DelMar Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com Jun 10, 2013
DelMar Pharmaceuticals Presents Additional Clinical Data from Ongoing Brain Cancer Study at ASCO Jun 3, 2013
DelMar Pharmaceuticals, Inc. to Webcast, Live, at RetailInvestorConferences.com June 6th May 31, 2013
DelMar Pharmaceuticals to Present Clinical Trials Data for VAL-083 Brain Cancer Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting May 28, 2013
DelMar Pharmaceuticals, Inc. Provides Corporate Update for the Quarter Ended March 31, 2013 May 16, 2013
DelMar Pharma Presents Encouraging Data From Ongoing Phase I/II GBM Clinical Trial With VAL-083 Apr 10, 2013
DelMar Pharmaceuticals to Present Clinical Data from VAL-083 Brain Cancer Trial at the American Association of Cancer Research Annual Meeting Apr 1, 2013
